A股收評:三大指數小幅收升,Kimi概念、低空經濟等板塊走高
A股主要指數今日小幅收升,截至收盤,滬指升0.55%報3079點,深證成指升0.21%,創業板指升0.12%。超3800股上升,全天成交1萬億元,為連續第3日突破萬億,北上資金淨買入55.68億元。盤面上,Kimi智能助手開啟內測,Kimi概念、AIGC概念及Sora概念等走高,掌閲科技等多股升停;低空經濟板塊反覆活躍,萊斯信息3天2板;教育板塊走強,美吉姆升停;AI手機概念股拉昇,福蓉科技3連板;高壓快充板塊震盪上行,科林電氣升停;數據要素、手遊概念及影視概念等升幅居前。另外,培育鑽石板塊走低,力量鑽石領跌;鋼鐵板塊走弱,*ST西鋼跌停;釀酒行業、機器人執行器及PLC概念等跌幅居前。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.